Fig. 5From: A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary interventionSensitivity analyses for internally and externally validating the predictive performance of the 6-metabolite model after stratification by initial clinical presentations and different components of MACEs. RF random forest; XGBoost gradient-boosted decision tree; ACS acute coronary syndrome; SCAD stable coronary artery disease; MI myocardial infarctionBack to article page